Everything you need to make the right decisions
Providing the most comprehensive and up-to-date information and analysis of the OTC Analgesics and Cold and Flu market, its consumers and the major players who make up that market.
Point of sale market data
In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on
How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios
What are the different segments within the market and how are those individual segments performing?
What are consumers looking for, what drives their buying habits and what are their main purchase influencers?
From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?
We gather our data from real-world consumers, selected to accurately reflect precise global demographics
What are the key players doing, what has been successful for them and what was their marketing spend?
Using data from our Global New Product Database, what products were launched and how well were they perceived?
What happens next, which areas are likely to experience growth and what opportunities exist within the market?
Expert analysis from a specialist in the field
Written by Lucy Cornford, a leading analyst in the Beauty & Personal Care, Household and Lifestyles sector, her extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.
A need to keep going at work is helping to keep the value of the category afloat, but it is increasingly under threat from consumers trading down to generic painkillers. Some adults are also turning to alternative methods of pain relief, potentially taking them away from buying OTC remedies, which suggests that brands could regain trust and engagement by promoting a more holistic approach to pain management.
Head of Beauty & Personal Care, Household and Lifestyles Research
Mintel has the answers you’re looking for
What are the key challenges facing the industry and how fast are its rates of growth? Who is the consumer and what do they want? Where are the opportunities, where are the risks and what lies ahead?
This report discusses the following key topics:
Products covered in this Report
This Report covers only over-the-counter (OTC), non-prescription
medication, defined by the Proprietary Association of Great Britain
‘Specifically designed to treat the symptoms of common, minor
and self-limiting ailments that do not require a medical diagnosis.’
They are divided into two categories:
- P: Pharmacy-only products, which can only be sold through
pharmacies by or in the presence of a qualified pharmacist
- GSL: General Sales List, which can be sold in any type of
This Report examines the UK consumer market for OTC
analgesics (also referred to as OTC painkillers and OTC pain
remedies). The OTC analgesics market is defined as including all
analgesics available over the counter without a prescription. This
includes topical analgesics (pain relief gels, creams and sprays),
alongside oral analgesics, oral lesions and toothache remedies.
The market definitions exclude certain other remedies, although
some are mentioned briefly in the competitive analysis and
elsewhere in the Report, ie:
- Homeopathic and other complementary medicines
- Products treating cold and flu symptoms (see Mintel’s Cough,
Cold, Flu and Allergy Remedies – UK, May 2017 Report)
Prescription-Only Medicines (POMs), which have to be prescribed
by a suitably qualified person and dispensed by a pharmacist, are
not included within the scope of this Report.